NM

Neelamma Mahantesh Patil

Active Director Director DIN 07530049
DIN 07530049 First appointment Jul 2016 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2016
Shareholding value •••• Premium profile

About Neelamma Mahantesh Patil

Data last updated:

Neelamma Mahantesh Patil is a Director at Suffice Pharmaceuticals Private Limited (since 2016). The company operates in Business Services. Suffice Pharmaceuticals Private Limited reported revenue of ₹4.8 Lakh (FY 2025).

DIN 07530049
Primary Designation Director
Industry Business Services
First Appointment 19 Jul 2016
Oldest Company Age 10 yrs
Largest company Suffice Pharmaceuticals Private Limited · ₹4.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jul 20162016₹4.8 Lakh (FY 2025)Active

Board colleagues of Neelamma Mahantesh Patil

Directorship timeline

Open interactive timeline →
Suffice Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neelamma Mahantesh Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelamma Mahantesh Patil

Neelamma Mahantesh Patil currently holds 1 directorship: Suffice Pharmaceuticals Private Limited (Director, since 19 Jul 2016, revenue ₹4.8 Lakh (FY 2025)).

Neelamma Mahantesh Patil was first appointed on 19 Jul 2016 as Director at Suffice Pharmaceuticals Private Limited.

The current boards of Neelamma Mahantesh Patil's companies include Mahantesh Patil Basavaraj (Suffice Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available